16P Camrelizumab monotherapy or plus apatinib for PD-L1-positive advanced pulmonary sarcomatoid carcinoma: A single-arm, open-label, multicenter, phase II study
Titel:
16P Camrelizumab monotherapy or plus apatinib for PD-L1-positive advanced pulmonary sarcomatoid carcinoma: A single-arm, open-label, multicenter, phase II study
Auteur:
Zhao, M. Liu, X. Yuan, C. Zheng, W. Zhang, D. Long, Q. Li, J. Han, T. Xu, L. Li, H. Li, X. Shi, S.